InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,316.52
(
-0.09%
)
US TECH 100
18,262.80
(
0.17%
)
Dow Jones
39,797.56
(
-0.19%
)
Brent Oil
81.79
(
-0.80%
)
Bitcoin
70,372.37
(
0.35%
)
Post# of 251894
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119670
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 206857

Saturday, 12/10/2016 9:25:48 AM

Saturday, December 10, 2016 9:25:48 AM

Post# of 251894

Solanezumab binds soluble a-beta. According to the "sink hypothesis" removing peripheral, soluble a-beta should impact the insoluble a-beta deposits in brain plaques, in order to maintain equilibrium between the two forms.

Thanks, Idit. So, is it fair to say that the “sink hypothesis” has been discredited by the latest Solanezumab findings?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up